.png)
The European pet food market is currently undergoing a transformation from a segment of simple household products to an advanced Pet Health sector. The dynamic increase in the awareness of animal keepers creates unique investment opportunities, but at the same time drastically raises the regulatory bar. In this context, a professional approach to R&D and the choice of a CDMO (Contract Development and Manufacturing Organization) partner becomes the foundation of the risk minimization strategy (de-risking). Basing your brand on hard scientific data is the only way to protect your reputation in an industry where dietary errors can result in immediate market foreclosure.
This guide is a stand-alone strategic compass for:
Understanding the business vision must be inextricably linked to hard legal realities, because in this ecosystem, an error in the naming of a product at the conceptual stage generates a legal risk that even the highest marketing budget does not eliminate.
--------------------------------------------------------------------------------
The first step to correct technical validation is to escape the nomenclature trap. In the European Union, under Regulation (EC) No 767/2009, the category “food supplement for animals” does not legally exist. Misclassification of a product may result in severe sanctions by GIW or WIJHARS, including the immediate withdrawal of the lot from the market.
Trait
Dietary Supplements (Human)
Complementary compound feed (Animal)
Legal basis
Food Safety Act
Regulation (EC) No 767/2009
Supervisory authority
GIS (Sanepid)
GIW (Veterinary) and WIJHARS (Quality)
Classification of ingredients
Food law
Catalogue of Feed Materials/Register of Additives
Registration Requirement
GIS Notification
Entry in the register of feed operators at PLW
Critical regulatory nuance: Dietary mixtures (PARNUT) and premixes According to the FEDIAF Marking Code (section 3.2.1.5.C), if the mixture contains additives in excess of 100 times the maximum limit established for complete feedingstuffs, must be classified as dietetic feed (PARNUT) or treated as a premix. Exceeding this threshold without a proper technical dossier makes the product illegal.
In conclusion, the concept of “supplement” is purely a marketing ploy. The investor introduces a complementary compound feed on the market, which imposes a strict selection of a production partner with veterinary rights.
--------------------------------------------------------------------------------
A CDMO partner in the veterinary sector has a completely different competence profile than a manufacturer of supplements for humans. Even with an outsourced production order, it is the brand owner who bears full responsibility for the product before the inspection bodies.
This is the absolute foundation of legality. The establishment must have a veterinary number assigned by the competent authority. Production in a plant without the so-called “Alpha” means that the product is illegal at the time of its creation, which makes it impossible to insure it and safely export it.
GMP+ or ISO 22000 certification guarantees full traceability of raw materials and rigorous monitoring of chemical and cross-contamination, which is essential in regulated production.
A professional CDMO should have its own laboratory capable of conducting Weende analysis (protein, fat, fiber, ash, moisture). This is the only evidence of professionalism and conformity of the composition accepted by the inspection bodies.
--------------------------------------------------------------------------------
The design of modern functional products must be based on science, not lifestyle trends. The overarching standard in the EU is the FEDIAF Nutrition Guidelines, developed by the Scientific Council (SAB).
When formulating, it is imperative to eliminate toxic substances, taking into account their legal status:
--------------------------------------------------------------------------------
Cost optimization in the CDMO model requires a strategic choice of the physical form of the product. At FoodUp Consulting we use the “Recipes for Friends” model — we create products that are safe, effective and profitable, eliminating unnecessary marketing costs hidden in the composition.
Physical form
Cost of production
Palatability (Dog/Cat)
Bioavailability
Investor Risk
Powders
low
Average
High
Low (Easy MOQ)
Tablets
Medium
High (with aromas)
Average
Medium (requires standardization)
Pastes/Gels
tall
Extreme (Cats)
Very high
High (expensive technology/packaging)
Avoiding hidden costs: The investor must take into account expenses for periodic laboratory tests (batch validation), label certification and packaging logistics (e.g. weight of glass bottles vs lightness of sachets). Building market advantage should be based on niche, high-margin solutions (e.g. kidney support, behaviorism) using clean labels.
--------------------------------------------------------------------------------
Marketing communication must be closely integrated into the technical dossier. Feed law strictly prohibits the use of medical terminology (treatment, prevention) in relation to compound feed.
In order to facilitate foreign expansion, brand owners should use official terminology pairs:
Analytical component
Unit
Terms of declaration
Crude Protein
%
Obligatory
Crude fiber
%
Obligatory
Crude fat
%
Obligatory
Crude ash
%
Obligatory
Humidity
%
Mandatory above 14% (according to 2022/1104 Part A, point 14c)
Key Distinction:
--------------------------------------------------------------------------------
Success in the Pet Health sector requires a shift from an emotional concept to a technical validation based on FEDIAF standards and pharmaceutical rigor.
Overarching principle: The product is supposed to work, be safe, and make money — in that exact order.
--------------------------------------------------------------------------------
ABOUT THE AUTHOR:
Maciej Jaskólski, MSc in Pharmacy
Pharmacist with more than 12 years of experience, specializing in the intersection of law, R&D and business in the Life Science industry. Founder of FoodUp Consulting. As an expert in regulated product implementations, he helps investors navigate safely between the requirements of the Chief Veterinary Inspectorate and the realities of contract production.
In his projects for the pet food industry, he combines a rigorous pharmaceutical approach with a love for animals, mercilessly eliminating ingredients from recipes that are just a marketing ploy.
Its goal is simple: your product is supposed to work, be safe, and make money — in that order.
Checklists of health labels and claims — how not to waste weeks on corrections